Complanatoside

Complanatoside is a flavonoid glycoside isolated primarily from Astragalus complanatus, structurally characterized as a kaempferol-based glycoside. Research on its pharmacological properties remains extremely limited, with no peer-reviewed studies establishing mechanisms of action or therapeutic applications.

Origin & History

Complanatoside A is a flavonoid glycoside (C27H30O18) characterized by a chromen-4-one core with two β-D-glucopyranosyl units. While related compounds occur in plants of the Cynanchum genus, the exact source organism for Complanatoside A remains unspecified in available databases. It appears as a yellow powder with molecular weight 642.52 g/mol.

Historical & Cultural Context

No information on traditional medicinal uses, historical context, or traditional medicine systems (Ayurveda, TCM) is available. The compound appears to be primarily a research-grade phytochemical without established traditional applications.

Health Benefits

• No documented health benefits - PubChem reports 0 literature references
• No clinical evidence from human trials exists
• No pharmacological mechanisms have been studied
• No traditional medicinal uses are documented
• No biomedical applications have been investigated

How It Works

Complanatoside belongs to the kaempferol glycoside class, suggesting a theoretical capacity to interact with antioxidant pathways common to flavonoids, such as Nrf2 signaling or free radical scavenging via hydroxyl groups on the phenolic ring. However, no published studies have characterized its binding to specific receptors, enzymes, or signaling proteins. Any mechanistic claims would be speculative extrapolations from structurally related compounds rather than direct experimental evidence.

Scientific Research

No clinical trials, randomized controlled trials, or meta-analyses exist for Complanatoside A. PubChem reports 0 literature references and no associated PMIDs for biomedical applications. The compound lacks any documented research beyond basic chemical characterization.

Clinical Summary

As of current literature, zero human clinical trials, animal pharmacology studies, or in vitro mechanistic investigations specific to complanatoside have been published, as reflected by PubChem's report of 0 literature references for this compound. No dose-response data, bioavailability measurements, or efficacy endpoints have been established. The absence of any preclinical data means evidence strength cannot be rated; it is simply nonexistent. Researchers have not yet investigated this compound in any documented biomedical context.

Nutritional Profile

Complanatoside is a flavonoid glycoside (specifically a flavonol glycoside) compound, not a food ingredient or nutritional source. It is chemically identified as a kaempferol-based glycoside isolated from plants such as Astragalus complanatus. As a pure isolated compound, it contains no macronutrients (0g protein, 0g fat, 0g dietary fiber in isolated form). Its molecular structure (C27H30O15, molecular weight approximately 594.52 g/mol) consists of a kaempferol aglycone core with attached sugar moieties. As a flavonoid, it belongs to the broader class of polyphenolic bioactive compounds. No nutritional concentration data exists in standardized food composition databases such as USDA FoodData Central or EFSA, as it is not consumed as a standalone nutrient. Trace amounts may be present in Astragalus complanatus seeds, though precise concentration data in plant material is not established in peer-reviewed nutritional literature. Bioavailability data is entirely absent; however, by structural analogy to similar flavonol glycosides, intestinal hydrolysis to release the kaempferol aglycone is plausible prior to absorption, though this remains unconfirmed for complanatoside specifically.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are documented as no human studies are available. Safety data is completely absent, including contraindications and toxicity profiles. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic combinations documented

Safety & Interactions

No safety profile, toxicology data, or adverse event reports exist for complanatoside in published scientific literature. Drug interaction potential is entirely unknown, as no studies have examined its metabolism via cytochrome P450 enzymes or transporter proteins such as P-glycoprotein. Contraindications for pregnant or breastfeeding individuals cannot be established due to a complete absence of reproductive toxicity data. Consumers should treat this compound as uninvestigated and consult a healthcare provider before use.